CytomX Therapeutics (CTMX) Share-based Compensation (QoQ) (2014 - 2026)
CytomX Therapeutics (CTMX) Share-based Compensation (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218.19% |
| Dec 31, 2025 | 84.87% |
| Sep 30, 2025 | 300.00% |
| Jun 30, 2025 | -90.04% |
| Mar 31, 2025 | 6.58% |
| Dec 31, 2024 | 44.48% |
| Sep 30, 2024 | -13.07% |
| Jun 30, 2024 | -21.34% |
| Mar 31, 2024 | -25.27% |
| Dec 31, 2023 | 108.16% |
| Sep 30, 2023 | -27.88% |
| Jun 30, 2023 | -29.43% |
| Mar 31, 2023 | 122.94% |
| Dec 31, 2022 | -556.52% |
| Sep 30, 2022 | 10.00% |
| Jun 30, 2022 | -37.95% |
| Mar 31, 2022 | -4.91% |
| Dec 31, 2021 | 93.03% |
| Sep 30, 2021 | -46.39% |
| Jun 30, 2021 | 12.89% |